While CXCL8 expression in MM cells is not directly associated with poor prognosis [45,46], higher serum levels of CXCL8 are linked to worse outcomes, likely due to its production by non-MM cells in the bone marrow microenvironment [68]. Here, CXCL8 is linked to Miyoshi myopathy.